Atrial Fibrillation: a Leading Cause of Heart Failure-related Hospitalizations; a Dual Epidemic

Overview

Journal Am J Cardiovasc Dis

Specialty Cardiology & Vascular Diseases

Date 2019 Nov 26

PMID 31763062

Citations 6

Authors

Asrar Ahmed

Waqas Ullah

Ishtiaq Hussain

Sohaib Roomi

Yasar Sattar

Faizan Ahmed

Rehan Saeed

Ammar Ashfaq

Affiliations

Soon will be listed here.

Abstract

Background: Atrial fibrillation (AF), and heart failure (HF) are a major cardiovascular epidemic over the last decade. The prevalence and rehospitalization of heart failure are on rising edge, and many factors are responsible for these re-exacerbations of heart failure. In this study, we sought to determine an association of a risk factor for frequent rehospitalization of heart failure at our institute. We aimed to find the re-admission rate, heart rate, and rhythm of heart failure exacerbation.

Methods: We performed a single-center retrospective study at the Abington Hospital - Jefferson health and 418 patients having a history of heart failure, and AF were selected. The heart failure readmission rate (days), heart rate, and rhythm were analyzed.

Results: The mean age of the included population was 82.8 years SD ± 9.2. About 53% had AF with a mean heart rate 90 SD ± 21 bpm, and 47% had normal sinus rhythm (NSR) with a mean heart rate of 78 ± 16 bpm on re-admission. This difference was statistically significant (p=0.02). The mean re-admission rate for atrial fibrillation was 27.49 days SD ± 18.97, compared to 32.68 SD ± 20.26 days for NSR, statistically significant (p=0.007) and the Pearson Chi-square was also significant P = 0.006.

Conclusion: There is a significantly increased rate of re-admission in heart failure patients with atrial fibrillation with a rapid ventricular rate. Efforts should be taken to keep the patient in NSR or controlled AF to minimize the rehospitalization rate, and this, in turn, reduces the financial burden on patients and institutes.

Citing Articles

A novel contact-free atrial fibrillation monitor: a pilot study.

Sadeh B, Merdler I, Sadon S, Lupu L, Borohovitz A, Ghantous E Eur Heart J Digit Health. 2023; 3(1):105-113.

PMID: 36713997 PMC: 9707913. DOI: 10.1093/ehjdh/ztab108.

Rhythm Control of Persistent Atrial Fibrillation in Systolic Heart Failure: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Khanra D, Deshpande S, Mukherjee A, Mohan S, Khan H, Kathuria S Int J Heart Fail. 2022; 3(3):179-193.

PMID: 36262637 PMC: 9536657. DOI: 10.36628/ijhf.2021.0008.

Same Day versus Overnight Discharge in Patients Undergoing Ablation for Atrial Fibrillation (SODA) Study.

Bailey S, Subramanian K, Sanchez J, Horton R, Natale A, Thambidorai S J Atr Fibrillation. 2021; 14(2):20200499.

PMID: 34950374 PMC: 8691271. DOI: 10.4022/jafib.20200499.

Current progress of computational modeling for guiding clinical atrial fibrillation ablation.

Wu Z, Liu Y, Tong L, Dong D, Deng D, Xia L J Zhejiang Univ Sci B. 2021; 22(10):805-817.

PMID: 34636185 PMC: 8505458. DOI: 10.1631/jzus.B2000727.

Sex Differences in the Association between Atrial Fibrillation and 90-Day Adverse Outcomes among Older Adults with Heart Failure: A Retrospective Cohort Study.

Son Y, Kim D, Won M Int J Environ Res Public Health. 2021; 18(5).

PMID: 33668276 PMC: 7967669. DOI: 10.3390/ijerph18052237.

References

Levy D, Larson M, Vasan R, Kannel W, Ho K . The progression from hypertension to congestive heart failure. JAMA. 1996; 275(20):1557-62. View

Braunstein J, Anderson G, Gerstenblith G, Weller W, Niefeld M, Herbert R . Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003; 42(7):1226-33. DOI: 10.1016/s0735-1097(03)00947-1. View

Ahmed M, White M, Ekundayo O, Love T, Aban I, Liu B . A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study. Eur Heart J. 2009; 30(16):2029-37. PMC: 2726959. DOI: 10.1093/eurheartj/ehp222. View

Wilhelmsen L, Rosengren A, Eriksson H, Lappas G . Heart failure in the general population of men--morbidity, risk factors and prognosis. J Intern Med. 2001; 249(3):253-61. DOI: 10.1046/j.1365-2796.2001.00801.x. View

Olsson L, Swedberg K, Ducharme A, Granger C, Michelson E, McMurray J . Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol. 2006; 47(10):1997-2004. DOI: 10.1016/j.jacc.2006.01.060. View

Corley S, Epstein A, DiMarco J, Domanski M, Geller N, Greene H . Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation. 2004; 109(12):1509-13. DOI: 10.1161/01.CIR.0000121736.16643.11. View

Dunlay S, Gheorghiade M, Reid K, Allen L, Chan P, Hauptman P . Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. Eur J Heart Fail. 2010; 12(4):367-74. PMC: 3732083. DOI: 10.1093/eurjhf/hfq019. View

Anter E, Jessup M, Callans D . Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009; 119(18):2516-25. DOI: 10.1161/CIRCULATIONAHA.108.821306. View

Giamouzis G, Kalogeropoulos A, Georgiopoulou V, Laskar S, Smith A, Dunbar S . Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions. J Card Fail. 2010; 17(1):54-75. DOI: 10.1016/j.cardfail.2010.08.010. View

10.

Lloyd-Jones D, Adams R, Brown T, Carnethon M, Dai S, de Simone G . Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation. 2009; 121(7):e46-e215. DOI: 10.1161/CIRCULATIONAHA.109.192667. View

11.

Koitabashi T, Inomata T, Niwano S, Nishii M, Takeuchi I, Nakano H . Paroxysmal atrial fibrillation coincident with cardiac decompensation is a predictor of poor prognosis in chronic heart failure. Circ J. 2005; 69(7):823-30. DOI: 10.1253/circj.69.823. View

12.

Beckman J, Creager M, Libby P . Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002; 287(19):2570-81. DOI: 10.1001/jama.287.19.2570. View

13.

Volz A, Schmid J, Zwahlen M, Kohls S, Saner H, Barth J . Predictors of readmission and health related quality of life in patients with chronic heart failure: a comparison of different psychosocial aspects. J Behav Med. 2010; 34(1):13-22. DOI: 10.1007/s10865-010-9282-8. View

14.

Amsalem Y, Garty M, Schwartz R, Sandach A, Behar S, Caspi A . Prevalence and significance of unrecognized renal insufficiency in patients with heart failure. Eur Heart J. 2008; 29(8):1029-36. DOI: 10.1093/eurheartj/ehn102. View

15.

Tsuchihashi-Makaya M, Kato N, Chishaki A, Takeshita A, Tsutsui H . Anxiety and poor social support are independently associated with adverse outcomes in patients with mild heart failure. Circ J. 2008; 73(2):280-7. DOI: 10.1253/circj.cj-08-0625. View

16.

Braunwald E . Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997; 337(19):1360-9. DOI: 10.1056/NEJM199711063371906. View

17.

Laing S, Swerdlow A, Slater S, Burden A, Morris A, Waugh N . Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia. 2003; 46(6):760-5. DOI: 10.1007/s00125-003-1116-6. View

18.

Paterson A, Rutledge B, Cleary P, Lachin J, Crow R . The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study. Diabetes Care. 2007; 30(8):2107-12. PMC: 2654598. DOI: 10.2337/dc06-1441. View

19.

Fang J, Mensah G, Croft J, Keenan N . Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol. 2008; 52(6):428-34. DOI: 10.1016/j.jacc.2008.03.061. View

20.

Wang T, Larson M, Levy D, Vasan R, Leip E, Wolf P . Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003; 107(23):2920-5. DOI: 10.1161/01.CIR.0000072767.89944.6E. View